406
Participants
Start Date
January 19, 2016
Primary Completion Date
January 24, 2018
Study Completion Date
October 31, 2018
SPI-2012
Single-use syringes for subcutaneous injection, administered on Day 2 of each cycle
Pegfilgrastim
Single-dose subcutaneous injection administered on Day 2 of each cycle
Docetaxel
Standard therapy
Cyclophosphamide
Standard therapy
North Shore Hematology Oncology Associates, East Setauket
Cha Bundang Medical Center, Seongnam-si
University of Pittsburgh Medical Center (UPMC), Pittsburgh
Associates in Hematology and Oncology, PC, Upland
RCCA MD LLC/The Center for Cancer and Blood Disorders, Bethesda
Delta Oncology Associates, Portsmouth
West Virginia University, Morgantown
Waverly Hematology Oncology, Cary
Bon Secours Saint Francis Cancer, Greenville
AnMed Health Cancer Center, Anderson
Carolina Blood and Cancer Care, Rock Hill
Dwight D. Eisenhower Army Medical Center, Fort Gordon
Memorial Health University Medical Center, Savannah
John B Amos Cancer Center, Columbus
Omega Research Consultants LLC, DeBary
Mid Florida Hematology and Oncology Centers, Orange City
Lakes Research, LLC, Miami Lakes
AMPM Research Clinic, Miami
Florida Cancer Research Institute, Plantation
Bond Clinic, P.A., Winter Haven
Pasco Pinellas Cancer Center, Holiday
The West Clinic, PC, d/b/a West Cancer Center, Germantown
Cookeville Regional Medical Center, Cookeville
Forrest General Hospital, Hattiesburg
Ashland-Bellefonte Cancer Center, Ashland
West Ky Hematology & Oncology Group, PSC, Paducah
Aultman Hospital, Canton
Gabrail Cancer Center Research, Canton
The Lindner Research Center at the Christ Hospital, Cincinnati
Franciscan St. Francis Health, Indianapolis
Northern Indiana Cancer Research Consortium, Westville
Floyd Memorial Cancer Center of Indiana, New Albany
Quest Research Institute, Royal Oak
St. Vincent Frontier Cancer Center, Billings
Oncology Specialists, SC, Park Ridge
Joliet Oncology Hematology Associates, Joliet
Clintell, Inc/Swedish Covenant Hospital, Chicago
Swedish American Cancer Center, Rockford
Carle Cancer Center, Urbana
Freeman Health Systems, Joplin
Southeast Nebraska Hematology & Oncology Consultants, PC, Lincoln
Saint Francis Cancer Treatment Center, Grand Island
Pontchartrain Cancer Center, Covington
Highland Clinic, Shreveport
Genesis Cancer Center, Hot Springs
Methodist Richardson Medical Center- Cancer Center, Richardson
Texas Oncology -Methodist Dallas Cancer Center, Dallas
Oncology Consultants, Houston
CHI St. Joseph Health Cancer Center, Bryan
Texas Oncology, PA, McAllen
Saint Alphonsus Regional Medical Center, Boise
Northern Utah Associates, Ogden
Arizona Center for Cancer Care, Glendale
Yuma Regional Medical Center, Yuma
Arizona Clinical Research Center/ ACRC, Tucson
Oncology Institute of Hope and Innovation, Whittier
Long Beach Memorial Medical Center, Long Beach
Pacific Shores Medical Group, Long Beach
Wellness Oncology Hematology, West Hills
Precision Research Institute, LLC, Chula Vista
Emad Ibrahim, MD, Inc., Redlands
Compassionate Cancer Care Medical Group, Inc, Riverside
Compassionate Care Research Group, Inc., Fountain Valley
Pacific Cancer Medical Center, Inc., Anaheim
Compassionate Cancer Care Medical Group, Inc., Corona
Ventura County Hematology-Oncology Specialists, Oxnard
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center, Bakersfield
Valley Medical Oncology Consultants, Pleasanton
Alta Bates Summit Medical Center, Berkeley
St Joseph Heritage Healthcare Institution, Santa Rosa
Good Samaritan Hospital Corvallis, Corvallis
Northwest Medical Specialties, PLLC, Tacoma
"NEA Baptist Clinic , Fowler Family Center for Cancer Care"
Penobscot Bay Medical Center, Rockport
Reliant Medical Group, Worcester
New Jersey Hematology Oncology Associates, Brick
Mercy Health Youngstown LLC DBA, Youngstown
CISSS de la Montérégie-Centre, Greenfield Park
Jewish General Hospital, Montreal
CHU de Quebec - Universite Laval, Québec
Severance Hospital, Sinchon-dong
Spectrum Pharmaceuticals, Inc
INDUSTRY